ciprofloxacin has been researched along with Shock, Cardiogenic in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin 500 mg was administered every 24 hours by nasogastric tube." | 1.28 | Absorption of oral ciprofloxacin in a patient with cardiogenic shock. ( Nightingale, C; Sullivan, M; Ujhelyi, MR, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ujhelyi, MR | 1 |
| Sullivan, M | 1 |
| Nightingale, C | 1 |
1 other study available for ciprofloxacin and Shock, Cardiogenic
| Article | Year |
|---|---|
Absorption of oral ciprofloxacin in a patient with cardiogenic shock.
Topics: Ciprofloxacin; Heart Ventricles; Humans; Intestinal Absorption; Intubation, Gastrointestinal; Male; | 1991 |